The Effectiveness of Almotriptan Malate (AXERT®) 12.5 Milligrams When Taken at the Onset of Migraine Pain
Clinical trial NCT00212823 · COMPLETED
Trial details
- NCT number
- NCT00212823
- Sponsor
- Ortho-McNeil Neurologics, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Enrollment
- 1450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.